Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma. (2021)
Attributed to:
BRIC: Packaging cell lines for inherently manufacturable viral vectors
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41375-021-01324-z
PubMed Identifier: 34145373
Publication URI: http://europepmc.org/abstract/MED/34145373
Type: Journal Article/Review
Volume: 35
Parent Publication: Leukemia
Issue: 12
ISSN: 0887-6924